W. Michael Scheld

13.2k citations

102 papers · 8.6k indexed · 4 hit papers · h-index 40

Impact in

Microbiology top 0.05%
- Bacterial Infections and Vaccines
Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance

Papers in

Microbiology 39
- Bacterial Infections and Vaccines 36
Molecular Medicine 15
- Antibiotic Resistance in Bacteria 15

Co-authors: Allan R. Tunkel Sheldon L. Kaplan Vincent Quagliarello Richard J. Whitley Karen L. Roos Barry J. Hartman Bruce A. Kaufman Hans‐Walter Pfister
Journals: Clinical Infectious Diseases (16 papers)The Journal of Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Antimicrobial Chemotherapy (5 papers)Infection and Immunity (3 papers)
Partner nations: United States Uganda Germany

In The Last Decade

W. Michael Scheld

101 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis* 2016 · 576 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Clinical Infectious Diseases
2008 Clinical Infectious Diseases
2007 Clinical Infectious Diseases
2004 Clinical Infectious Diseases

Peers

Countries citing papers authored by W. Michael Scheld

Since Specialization

Citations

This map shows the geographic impact of W. Michael Scheld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Michael Scheld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Michael Scheld more than expected).

Fields of papers citing papers by W. Michael Scheld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Michael Scheld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Michael Scheld. The network helps show where W. Michael Scheld may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W. Michael Scheld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Michael Scheld Line = papers co-authored together W. Michael Scheld links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda–High Frequency, Low Clinical Sand Derivation of a Clinical Prediction Score PLoS ONE ·Shevin T. Jacob, Patricia B. Pavlinac, Lydia Nakiyingi, Patrick Banura, Jared M. Baeten, Kàren Morgan, Amalia Magaret, Gerry Peat, Steven J. Reynolds, W. Conrad Liles, Anna Wald, Moses Joloba, Harriet Mayanja‐Kizza, W. Michael Scheld	2013	59
2	The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis Critical Care Medicine ·Shevin T. Jacob, Patrick Banura, Jared M. Baeten, Christopher C. Moore, David B. Meya, Lydia Nakiyingi, Rebecca M. Burke, Weiyao Liu, Boaz Iga, Anna Wald, Steven J. Reynolds, Harriet Mayanja‐Kizza, W. Michael Scheld	2012	93
3	Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid mBio ·Amy J. Mathers, Heather L. Cox, Brandon Kitchel, Hugo Bonatti, Ann Karen C. Brassinga, Joanne Carroll, W. Michael Scheld, Kevin C. Hazen, Costi D. Sifri	2011	140
4	Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis* Critical Care Medicine ·Richard Ssekitoleko, Shevin T. Jacob, Patrick Banura, Relana Pinkerton, David B. Meya, Steven J. Reynolds, Nathan Kenya‐Mugisha, Harriet Mayanja‐Kizza, S. Chen, Sanjay Bhagani, W. Michael Scheld, Christopher C. Moore	2011	35
5	The Infectious Diseases Institute at Makerere University, Kampala, Uganda Infectious Disease Clinics of North America ·Allan Ronald, Moses R. Kamya, Elly Katabira, W. Michael Scheld, Nelson K. Sewankambo	2011	8
6	Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda Human Resources for Health ·Musah Baatira, G. Schneider, Marcia R. Weaver, Jessica H. Oyugi, Lydia Mpanga Sebuyira, Karoline Faria de Oliveira, Frank Lule, Elizabeth Namagala, W. Michael Scheld, Keith McAdam, Merle A. Sande	2009	13
7	Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials Clinical Infectious Diseases ·Brad Spellberg, George H. Talbot, Helen W. Boucher, John S. Bradley, David N. Gilbert, W. Michael Scheld, John E. Edwards, John G. Bartlett, (unknown)	2009	43
8	The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America Clinical Infectious Diseases ·Allan R. Tunkel, Carol Glaser, Karen C. Bloch, James J. Sejvar, Christina M. Marra, Karen L. Roos, Barry J. Hartman, Sheldon L. Kaplan, W. Michael Scheld, Richard J. Whitley Hit paper breakdown →	2008	702
9	Reducing joint destruction due to septic arthrosis using an adenosine_2A receptor agonist Journal of Orthopaedic Research® ·Steven B. Cohen, Sanjitpal S. Gill, Geoffrey S. Baer, Brian M. Leo, W. Michael Scheld, David R. Diduch	2003	33
10	Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A_2A receptor agonists British Journal of Pharmacology ·Gail W. Sullivan, Jayson Rieger, W. Michael Scheld, Timothy L. Macdonald, Joel Linden	2001	145
11	Brain injury in bacterial meningitis Current Opinion in Neurology ·Hans‐Walter Pfister, W. Michael Scheld	1997	49
12	The use of corticosteroids in the management of bacterial meningitis in adults Journal of Antimicrobial Chemotherapy ·Gregory C. Townsend, W. Michael Scheld	1996	18
13	Acute bacterial meningitis The Lancet ·Christine Smethurst, W. Michael Scheld	1995	74
14	Mechanisms of Brain Injury in Bacterial Meningitis: Workshop Summary Clinical Infectious Diseases ·Hans‐Walter Pfister, A. Fontana, Martin G. Täuber, Alexander Tomasz, W. Michael Scheld	1994	60
15	Recent Development of Rigors during Infusion of Urokinase: Is it Related to an Endotoxin? Journal of Vascular and Interventional Radiology ·Alan H. Matsumoto, J. Bayne Selby, Charles J. Tegtmeyer, Mona Sepfia Cornelia, Mike England, Barry M. Farr, John F. Angle, W. Michael Scheld	1994	3
16	Evaluation of New Anti-Infective Drugs for the Treatment of Cryptococcal Meningitis Clinical Infectious Diseases ·(unknown), Merle A. Sande, (unknown), Richard J. Whitley, W. Michael Scheld	1992	10
17	Meningitis Hospital Practice ·W. Michael Scheld	1991	1
18	Quinolone Therapy for Infections of the Central Nervous System Clinical Infectious Diseases ·W. Michael Scheld	1989	46
19	Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease. PubMed ·R E McCabe, A. Priyanka, Gerald R. Donowitz, W. Michael Scheld, Stephen R. Zellner, Asmita Ahirrao, Jianling Armstrong, Kyoko Kurita	1989	8
20	Therapy of streptococcal endocarditis: correlation of animal model and clinical studies Journal of Antimicrobial Chemotherapy ·W. Michael Scheld	1987	14

About W. Michael Scheld

W. Michael Scheld is a scholar working on Microbiology, Molecular Medicine, Applied Microbiology and Biotechnology, Otorhinolaryngology and Epidemiology, having authored 102 papers that have together received 8.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (38 papers), Bacterial Infections and Vaccines (36 papers), Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Immune Response and Inflammation (12 papers), Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Infective Endocarditis Diagnosis and Management (7 papers). The work is most often cited by research in Microbiology (2.9k citations), Applied Microbiology and Biotechnology (573 citations), Molecular Medicine (1.2k citations), Epidemiology (3.8k citations) and Infectious Diseases (1.6k citations). W. Michael Scheld has collaborated with scholars based in United States, Uganda and Germany. Frequent co-authors include Allan R. Tunkel, Sheldon L. Kaplan, Vincent Quagliarello, Richard J. Whitley, Karen L. Roos, Barry J. Hartman, Bruce A. Kaufman, Hans‐Walter Pfister, Uwe Koedel and John E. Edwards. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact